Silgan Holdings (SLGN) Q4 2025 earnings review
Growth Engine Stalls on Non-Operational Headwinds
Silgan reported a mixed Q4 where operational gains were erased by financial headwinds. While Revenue grew 4% YoY to $1.5B, Adjusted EPS plummeted 21% to $0.67, significantly trailing the prior year's $0.85. The culprit is not demand—Pet Food volumes surged 7% and Fragrance grew double-digits—but a sharp rise in interest expense (bond maturities) and an unfavorable tax rate. Management's FY26 guidance ($3.70–$3.90 EPS) implies stagnation (+2% YoY at midpoint) and Q1 2026 is guided down (-9% YoY), signaling that the earnings recession will persist through the first half of the new year.
🐂 Bull Case
Metal Containers delivered strong 7% volume growth in Pet Food, which now accounts for over 50% of the segment. The category is proving resilient and recession-proof, driving total segment volume up 4%.
The Dispensing segment (DSC) saw double-digit growth in high-value Fragrance and Beauty products. The integration of Weener Packaging is complete, with synergies fully achieved, positioning this high-margin unit for long-term gains.
🐻 Bear Case
Q4 Adjusted EPS fell 21% and Q1 2026 guidance implies a further 9% drop. Higher interest expenses (+$20M expected in 2026 vs 2025) and tax headwinds are masking operational improvements.
While Beauty is strong, the 'bifurcated consumer' trend hit the Personal and Home Care markets, causing destocking in Q4. This weakness, combined with inventory headwinds, is dragging on DSC profitability entering 2026.
⚖️ Verdict: 🔴
Bearish. Operational pockets of strength (Pet Food, Fragrance) are overshadowed by a deteriorating earnings profile driven by capital structure costs and tax rates. With negative earnings growth projected for Q1 2026 and flat full-year guidance, the immediate catalyst for stock appreciation is absent.
Key Themes
Financial Weight: Interest & Tax
The earnings story has shifted from operational growth to financial defense. Interest expense is guided to ~$205M for FY26 (up from ~$185M run rate), driven by the refinancing of 1.4% senior notes coming due in April. Additionally, the tax rate is rising to 25-26% due to geographic mix and non-recurring items. These two lines are single-handedly capping EPS growth despite projected volume gains.
Pet Food Powerhouse
Accelerating. Metal Containers volume grew 4% overall, led by a robust 7% jump in Pet Food. This high-margin category now represents >50% of the segment's volume. Management noted a 'limited amount of pre-buy' in Q4 but maintained a confident outlook for mid-single-digit growth in 2026, validating the defensive nature of the portfolio.
Dispensing Segment Drag
Decelerating. While sales rose 1% in Q4, Adjusted EBIT was merely flat despite the Weener acquisition contribution. The segment faced a 'headwind' from selling through low-cost inventory in 2025, which flips to a negative variance in 2026. Q1 2026 DSC EBIT is explicitly guided to be *below* prior year levels, proving that the destocking in Home/Personal care has lingering margin consequences.
Custom Containers Optimization
Stable. Revenue fell 8% in Q4, but this was intentional. The company exited low-margin business as part of a footprint optimization plan. Excluding these exits, volume actually grew +1%. EBIT margins expanded ~150bps for the full year. FY26 volumes are expected to be flat as the destocking carryover hits Q1, but profitability quality has structurally improved.
Metal Customer Bankruptcy
While management claims to have 'protected the business,' the bankruptcy of a major fruit/veg customer is still creating noise. The situation is 'not fully resolved' regarding asset ownership. While Silgan expects to retain the volume due to co-location, the uncertainty prevents this segment from fully normalizing in the first half of 2026.
Other KPIs
Management noted they 'delivered... adjusted EBITDA' essentially in line with targets. However, margin expansion is fighting against volume mix shifts. The Dispensing segment now represents over half of Adjusted EBITDA, marking a permanent structural shift away from the legacy Metal Containers dominance.
FCF remains a bright spot, coming in as the second highest in history. The company returned ~$150M to shareholders. However, FY26 FCF guidance is $450M, implying only marginal growth (~4-5%) despite the projected operating income improvements, dampening hopes for massive buybacks.
Just over a year after the Weener acquisition, leverage has returned to the target range (2.5x-3.5x). This rapid deleveraging is positive, but the rising cost of debt (refinancing 1.4% notes into a higher rate environment) punishes the income statement even as the balance sheet health improves.
Guidance
Stable/Stagnant. The midpoint of $3.80 implies only ~2% growth over FY25's $3.72. This is a deceleration from the double-digit growth seen earlier in 2025. Higher interest expense ($205M) and taxes (25-26%) are consuming almost all operational gains.
Reversing. Midpoint ($0.75) is down ~9% vs 25Q1 ($0.82). This signals a rough start to the year, driven by DSC inventory headwinds and carryover destocking in Custom Containers.
Stable. A slight increase from FY25 levels (~$430M). Capex is rising to ~$310M to support growth in dispensing and pet food, limiting FCF expansion.
DSC: Low-to-mid single digit growth (Accelerating vs Q4). Metal: Low single digit growth (Stable). Custom: Flat (Decelerating due to Q1 destocking).
Key Questions
DSC Margin Compression Duration
Q1 DSC EBIT is guided down due to inventory accounting headwinds. Is this strictly a Q1 phenomenon, or will the 'selling through high-cost inventory' drag persist into H2 2026?
Pet Food Pre-Buy Risk
You mentioned a 'limited amount of pre-buy' in Q4 for Metal Containers. How much of the Q1/2026 forecast is at risk if customers destock this pre-bought inventory?
Pricing Power in Metal
With raw materials inflating again and tariffs in play, do you have full pass-through ability in 2026, or will there be a lag that temporarily compresses margins as seen in prior cycles?
Interest Expense Plateau
Is the $205M interest expense guidance a new structural baseline, or does the deleveraging pace offer a path to reduce this number significantly in 2027?